AstraZeneca Cash from Investing Quarterly:
-364.00M for March 31, 2013AstraZeneca Historical Cash from Investing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -364.00M |
| Dec. 31, 2012 | -514.00M |
| Sept. 30, 2012 | -2.698B |
| June 30, 2012 | 760.00M |
| March 31, 2012 | 593.00M |
| Dec. 31, 2011 | -3.58B |
| Sept. 30, 2011 | 1.272B |
| June 30, 2011 | 186.00M |
| March 31, 2011 | 100.00M |
| Dec. 31, 2010 | -452.00M |
| Sept. 30, 2010 | 258.00M |
| June 30, 2010 | -925.00M |
| March 31, 2010 | -1.107B |
| Dec. 31, 2009 | -1.904B |
| Sept. 30, 2009 | -410.00M |
| June 30, 2009 | -236.00M |
| March 31, 2009 | 74.00M |
| Dec. 31, 2008 | -472.00M |
| Sept. 30, 2008 | -225.00M |
| June 30, 2008 | -262.00M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
AZN Cash from Investing Quarterly Benchmarks
| Companies | |
|---|---|
| GlaxoSmithKline | -452.89M |
| Pfizer | |
| Merck |
AZN Cash from Investing Quarterly Rankings
| Overall |
45th percentile 4114 of 7590 |
| Sector |
18th percentile 532 of 651 in Healthcare |
| Industry |
32nd percentile 35 of 52 in Drug Manufacturers - Major |
AZN Cash from Investing Quarterly Range, Past 5 Years
| Minimum | -3.58B | Dec 2011 |
| Maximum | 1.272B | Sep 2011 |
| Average | -495.30M |
